Succinylcholine Chloride
These highlights do not include all the information needed to use SUCCINYLCHOLINE CHLORIDE INJECTION safely and effectively. See full prescribing information for SUCCINYLCHOLINE CHLORIDE INJECTION. SUCCINYLCHOLINE CHLORIDE injection, for intramuscular and intravenous use. Initial U.S. Approval: 1952
Approved
Approval ID
cb5b3361-9099-4a12-b545-f1e50b0781dd
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 2, 2024
Manufacturers
FDA
Hikma Pharmaceuticals USA Inc.
DUNS: 946499746
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Succinylcholine Chloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0641-6234
Application NumberNDA215143
Product Classification
M
Marketing Category
C73594
G
Generic Name
Succinylcholine Chloride
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateJanuary 2, 2024
FDA Product Classification
INGREDIENTS (5)
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
SUCCINYLCHOLINE CHLORIDE DIHYDRATEActive
Quantity: 20 mg in 1 mL
Code: 8L0S1G435E
Classification: ACTIR